Autotransfusion Devices and Consumables Market by Product Type (Devices and Consumables) and End Use (Hospitals, Ambulatory Surgical Settings, and Others): Global Opportunity Analysis and Industry Forecast, 20192026
- Published Date: 2020-10-18
- Report ID: 3538
- Pages: 250
-
Format:
Autotransfusion is a process of blood transfusion where the blood of the patient is extracted from the site of wound, which then gets filtered and purified. This blood is then infused back to the patients body. Autotransfusion is used in several surgeries such as cardiovascular surgery, orthopedic surgeries, surgeries related to trauma and during liver and other types of transplantation. The global autotransfusion devices and consumables market was valued at $864 million in 2018, and is estimated to reach $1,380 million by 2025, growing at a CAGR of 6.1% from 2019 to 2026.
The increase in the use of autotransfusion devices and consumables is due to its advantages over allogeneic techniques in preventing the risk of transfusion transmitted infection. In addition, the increase in the prevalence of cardiovascular diseases, trauma, transplantation and rise in technological advancements in blood transfusion techniques drive the autotransfusion devices and consumables market growth and is expected to follow the trend throughout the forecast period. Moreover, increase in government initiatives and focus on safe autotransfusion programs boosts the market growth. However, poor quality purification and improper mixing of blood components and a global shortage of autotransfusion can restrain the market growth. Furthermore, untapped market potential in developing regions is expected to provide lucrative opportunities for the market development.
This report segments the autotransfusions sales market based on product type, end use, and region to provide a detailed assessment of the market. Based on product type, it is bifurcated into devices and consumables. The devices segment is further categorized into on-pump transfusion devices and off-pump transfusion devices. Based on end use, the market is categorized into hospitals, ambulatory surgical devices, and others. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
North America is the highest contributor for the growth of autotransfusion devices and consumables market, owing to better healthcare infrastructure and technological advancement in the region along with high disposable incomes and preference over allogenic transfusion techniques by the healthcare professionals and patient population alike. North America is expected to continue this trend during the forecast period. Asia-Pacific is the fastest growing region for the autotransfusion devices and consumables market and is anticipated to remain dominant throughout the forecast period.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the autotransfusion devices and consumables market along with the current trends and future estimations to elucidate the imminent investment pockets.
A quantitative analysis from 2018 to 2026 is discussed to enable the stakeholders to capitalize on the prevailing market opportunities.
In-depth analysis of market based on product type such as devices and consumables are carried out in the report.
The global autotransfusion devices and consumables market scenario is comprehensively analyzed in accordance to the key cities.
KEY MARKET SEGMENTS
By Product Type
Devices
o On-pump Transfusion Devices
o Off-pump Transfusion Devices
Consumables
By End Use
Hospitals
Ambulatory Surgical Centres
Others
By Region
North America
o U.S.
o Canada
o Mexico
Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
Asia-Pacific
o Japan
o China
o Australia
o India
o Rest of Asia-Pacific
LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT (DEVICE PROVIDERS)
Becton, Dickinson and Company (C.R. Bard)
Brightwake Ltd.
Fresenius
Getinge AB
Haemonetics Corporation
LivaNova PLC
Medtronic Plc
Stryker
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Research methodology
1.2.1. Secondary research
1.2.2. Primary research
1.2.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings
2.1.1. Top investment pockets
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Parent Market Overview
3.3. Key Forces Shaping Autotransfusion devices and consumables market
3.3.1. Moderate bargaining power of suppliers
3.3.2. High bargaining power of buyers
3.3.3. High threat of new entrants
3.3.4. Moderate threat of substitutes
3.3.5. High intensity of rivalry
3.4. Pricing Analysis
3.4.1. Pricing Analysis, By Region, 2018 & 2025
3.5. Market evolution/Industry roadmap
3.6. Value Chain Analysis
3.7. Impact of government regulations on global autotransfusion devices and consumables market
3.8. Industry pain point analysis
3.9. Patent Analysis
3.9.1. By Region (2016-2018)
3.9.2. By Applicant
3.10. Market share analysis
3.11. Case Studies
3.11.1. Case Study
3.12. Market dynamics
3.12.1. Drivers
3.12.1.1. Technological advancement in the Autotransfusion system
3.12.1.2. Increased prevalence of Cardiovascular diseases
3.12.2. Restraints
3.12.2.1. Lack of skilled technicians for handling the Autotransfusion System
3.12.3. Opportunities
3.12.3.1. Increased adoption of Autotransfusion system
CHAPTER 4: AUTOTRANSFUSION DEVICES AND CONSUMABLES MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Devices
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.2.4. On Pump Transfusion Devices
4.2.4.1. Key market trends and opportunities
4.2.4.2. Market size and forecast
4.2.4.3. Market analysis, by country
4.2.5. Off-Pump Transfusion Devices
4.2.5.1. Key market trends and opportunities
4.2.5.2. Market size and forecast
4.2.5.3. Market analysis, by country
4.3. Consumables
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast
4.3.4. Market analysis, by country
CHAPTER 5: AUTOTRANSFUSION DEVICES AND CONSUMABLES MARKET, BY END USE
5.1. Overview
5.1.1. Market size and forecast
5.2. Hospitals
5.2.1. Key market trends and opportunities
5.2.2. Market size and forecast
5.2.3. Market analysis, by country
5.3. Ambulatory Surgical Centers
5.3.1. Key market trends and opportunities
5.3.2. Market size and forecast
5.3.3. Market analysis, by country
5.4. Others
5.4.1. Key market trends and opportunities
5.4.2. Market size and forecast
5.4.3. Market analysis, by country
CHAPTER 6: AUTOTRANSFUSION DEVICES AND CONSUMABLES MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. North America market size and forecast, by Product type
6.2.3. North America market size and forecast, by end use
6.2.5. North America market size and forecast, by country
6.2.5.1. U.S. market size and forecast, by product type
6.2.5.2. U.S. market size and forecast, by end use
6.2.5.4. Canada market size and forecast, by product type
6.2.5.5. Canada market size and forecast, by end use
6.2.5.6. Mexico market size and forecast, by product type
6.2.5.7. Mexico market size and forecast, by end use
6.3. Europe
6.3.1. Key market trends and opportunities
6.3.2. Europe market size and forecast, by product type
6.3.3. Europe market size and forecast, by end use
6.3.4. Europe market size and forecast, by country
6.3.4.1. Germany market size and forecast, by product type
6.3.4.2. Germany market size and forecast, by end use
6.3.4.3. France market size and forecast, by product type
6.3.4.4. France market size and forecast, by end use
6.3.4.6. UK market size and forecast, by product type
6.3.4.7. UK market size and forecast, by end use
6.3.4.8. Italy market size and forecast, by product type
6.3.4.9. Italy market size and forecast, by end use
6.3.4.10. Spain market size and forecast, by product type
6.3.4.11. Spain market size and forecast, by end use
6.3.4.12. Rest of Europe market size and forecast, by product type
6.3.4.13. Rest of Europe market size and forecast, by end use
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Asia-Pacific market size and forecast, by product type
6.4.3. Asia-Pacific market size and forecast, by end use
6.4.4. Asia-Pacific market size and forecast, by country
6.4.4.1. Japan market size and forecast, by product type
6.4.4.2. Japan market size and forecast, by end use
6.4.4.3. China market size and forecast, by product type
6.4.4.4. China market size and forecast, by end use
6.4.4.5. India market size and forecast, by product type
6.4.4.6. India market size and forecast, by end use
6.4.4.7. Australia market size and forecast, by product type
6.4.4.8. Australia market size and forecast, by end use
6.4.4.9. Rest of Asia-Pacific market size and forecast, by product type
6.4.4.10. Rest of Asia-Pacific market size and forecast, by end use
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. LAMEA market size and forecast, by product type
6.5.3. LAMEA market size and forecast, by end use
6.5.4. LAMEA market size and forecast, by country
6.5.4.1. Brazil market size and forecast, by product type
6.5.4.2. Brazil market size and forecast, by end use
6.5.4.3. South Africa market size and forecast, by product type
6.5.4.4. South Africa market size and forecast, by end use
6.5.4.5. Rest of LAMEA market size and forecast, by product type
6.5.4.6. Rest of LAMEA market size and forecast, by end use
CHAPTER 7: COMPANY PROFILES
7.1. Becton, Dickinson and Company (C.R. Bard)
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.2. Brightwake Ltd.
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segment
7.2.4. Product portfolio
7.3. Fresenius
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. Getinge AB
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.5. Haemonetics Corporation
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.6. LivaNova PLC
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.7. Medtronic Plc.
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.8. Stryker
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
